Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

The study, published this week in the Journal of Infectious Diseases, found that antibiotic exposure before age 2 years was ...

Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...